Medical Oncology

The department of Medical Oncology in Vydehi Cancer Centre has a dedicated and compassionate team of super-specialists who practice evidence-based cancer care for the management of solid and haematological malignancies in children and adults.
From its inception in 2007, the Department of Medical Oncology has been involved in patient care services in almost all divisions of Oncology including Breast, Gastrointestinal, Head & Neck, Lung, Bone, Soft tissue sarcomas, Gynaeconcology, Uro-oncology, Leukemia, Lymphoma and Pediatric tumours.
The Department of Medical Oncology is one of the most cost-effective center of South India and provides specialised services in Inpatient and Day care setting and these services include both Allogenic and Autologous Stem cell transplant, HIPEC(Hyper thermic Intraperitoneal chemotherapy), Immunotherapy, Targeted treatment , Hormonal treatment , Intravesical Chemotherapy and Intrathecal Chemotherapy apart from Conventional Chemotherapy.
Complete spectrum of diagnostic services available at our centre that includes PET-CT/ PSMA-PET, Cytogenetics and Molecular Genetics.

Professor & HOD

Dr.Shashidhar V Karpurmath

MBBS,MD, DM
Karnataka State Medical
Council Registration Number
63461

Professor

Dr.Manjunath Nandennavar

MBBS,MD,DM
Karnataka State Medical
Council Registration Number
58014

Assistant Professor

Dr.Veerendra Angadi

MBBS,MD,DM
Karnataka State Medical
Council Registration Number
87541

Senior Resident

Dr.Santoshkumar S Asangi

MBBS,MD, DNB,FNB
Karnataka State Medical Council Registration Number
98543

Senior Resident

Dr.Chevireddy Praneetha

MBBS,MD
Karnataka State Medical
Council Registration Number
89296

Senior Resident

Dr A Praneeth Kumar

MBBS,DNB
Karnataka State Medical
Council Registration Number
106908

Senior Resident

Dr.Geetika Dandamudi

MBBS,MD
Karnataka State Medical
Council Registration Number
157862

Senior Resident

Dr.Mohammed Hafeez

MBBS,MD
Karnataka State Medical
Council Registration Number
95229

Senior Resident

Dr.Nitesh Anand

MBBS, DNB
Karnataka State Medical
Council Registration Number
156834

Senior Resident

Dr.Pooja D

MBBS, MD
Karnataka State Medical
Council Registration Number
116247

Senior Resident

Dr.Prakash Shashikant Mishra

MBBS,DNB
Karnataka State Medical
Council Registration Number
69815

Senior Resident

Dr.Ranjitha Raj

MBBS, MD
Karnataka State Medical
Council Registration Number
112148

Senior Resident

Dr.Sachet Saxena

MBBS,MD
Karnataka State Medical
Council Registration Number
63461

Senior Resident

Dr.Shruthi Swamy

MBBS,MD
Karnataka State Medical
Council Registration Number
104140

Senior Resident

Dr.Shubha Supriya A

MBBS,DNB
Karnataka State Medical
Council Registration Number
109702

Senior Resident

Dr.Vishnu Vardhan Juture

MBBS, MD
Karnataka State Medical
Council Registration Number
954147

Senior Resident

Dr.Yedla Srinivasa Vishnuvardhan

MBBS,MD
Karnataka State Medical
Council Registration Number
1503374

Senior Resident

Dr.Yogitha C

MBBS,DNB
Karnataka State Medical
Council Registration Number
125636

- Day care Chemotherapy services for various solid malignancies like cancers of breast, lung , colon , stomach , prostate , cervix , head and neck etc
- Day care Chemotherapy services for various hematological malignancies like Non- Hodgkins Lymphoma, Hodgkins Lymphoma , Multiple myeloma etc
- Inpatient facilities for treatment of various hematologic malignancies like blood cancers (Acute Lymphoblastic Leukemia’s , Acute Myeloid Leukemia’s, Chronic Lymphocytic Leukemia’s , Chronic Myeloid leukemia’s )
- Inpatient facilities for administration of neo-adjuvant and adjuvant chemotherapies for bone cancers and soft tissue sarcomas
- Sophisticated and Dedicated Bone Marrow Transplant ( Stem cell transplant ) unit for performing Allogenic and Autologous transplants
- Immunotherapy and Monoclonal antibody treatment for various cancers
- HIPEC (Heated Intraperitoneal Chemotherapy) administration for various cancers like ovarian cancers, stomach and colon cancers, pseudomyxoma peritonea.
- Intrathecal chemotherapy administration for various hematological cancers
- Hormonal treatment for various cancers like breast, prostate etc.
Supportive services
- Bone marrow aspiration /Bone marrow biopsies
- Intrathecal chemotherapy administration
- Lumbar punctures / abdominal and thoracic Paracentesis (Ascitic and pleural fluid tapping)
- Chemo port access , flushing and dressing
Specialty Clinics
- Leukemia Clinic- Tuesdays , 11:00 am to 1:00 pm
- Breast Clinic – Wednesdays , 11:00 am to 1:00 pm
- Gynaecology-oncology Clinic – Thursdays , 11:00 am to 1:00 pm

Outpatient Facilities

Outpatient consultation rooms with waiting zone
Counselling rooms
Minor OT
Day care facility
Medical Social worker Services
Preventive Oncology OPD

Inpatient Facilities

Dedicated Bone Marrow Transplant Unit for both Allogenic and Autologous Stem cell Transplants
Medical Oncology wards with dedicated , well trained and compassionate nursing staff with separate male and Female wards
Intensive care unit with well-trained Intensivist
Paediatric intensive Care Unit with trained pediatricians
Interventional Radiology services –
Image guided biopsies
b.Central Venous catheters – PORT , PICC (peripherally inserted central catheter)
c.Nerve blocks for pain palliation
d.Transarterial Chemoembolisation
e.Radio frequency ablation
Diagnostic facilities
Immunohistochemistry
b.Flow cytometry
c.Cytogenetics
d.Molecular tests like RT PCR
e.NGS (Next Generation Sequencing)
Pain and palliative unit
Morphine
b.Nerve Blocks
c.High frequency ultrasound / microwave heat therapy
24 hours blood and blood components support
24 hours radiology services like ultrasound/CT /MRI/Mammography/ X ray/PET CT Scan.

Publications from the department during the past 05 years: Number of Yearly research publications* by the teaching staff in 2018

S no	Author 1st, 2nd and corresponding author	Title of paper	National or International	Citation of the journal	Indexing details	Date of publication	Pageno, vol,ISSN no
1.	Dr. Shashidhar V Karpurmath ( First Author )	Role of preoperative CA-125 levels in predicting the DFS and OS in epithelial ovarian cancer.	International	Karpurmath SV, Vivek VS, Nandennavar MI, Angadi V, Sekar A. Role of preoperative CA-125 levels in predicting the DFS and OS in epithelial ovarian cancer. Int J Reprod Contracept Obstetric Gynecology 2018; 7:69-73.	1.Google Scholar 2.Pubmed Central 3.Index Copernicus 4. Index Medicus	Jan 2018	69-73

Number of Yearly research publications* by the teaching staff in 2019

Sl. No	Author 1st, 2nd and corresponding author	Title of paper	National or international	Citation of the journal	Indexing details	Date of publication	Pageno, vol, ISSN no
1	DR Shashidhar V Karpurmath (Second Author)	Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence.	International	Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, et al. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. JGO. 2019 Dec;1-13	1.Index Medicus/Medline, 2.Dimensions, 3.Directory Of Open Access Journals, 4.Web Of Science 5.Scopus	December 2019	1-13
2	DR Shashidhar V Karpurmath ( Second Author )	The correlation of doxorubicin related cardiotoxicity with B-type natriuretic peptide levels in South Indian population.	International	Jacob DRK, Karpurmath DSV, Nandennavar DM, Angadi DV. The correlation of doxorubicin related cardiotoxicity with B-type natriuretic peptide levels in South Indian population. Int J Med Res Rev. 2019 Dec 31; 7(6):452-60.	1.Sciencecentral.Com, 2.Index Medicus	December 2019	452-460
3	DR Shashidhar V Karpurmath (second author)	Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population.	International	Jacob RK, Karpurmath SV, Nandennavar M, Angadi V. Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population. Int J Res Med Sci. 2019 Oct 24;7(11):4298.	1.Google Scholar, 1. ISSN, 3.Index Copernicus	October 2019	4298
4	DR Veerendra Angadi (First Author)	Packed red cell blood transfusion practices review in medical oncology unit in a tertiary cancer center, South India.	International	Angadi V, Nandennavar M, Karpurmath SV, Jacob R, Donekal Y. Packed red cell blood transfusion practices review in medical oncology unit in a tertiary cancer center, South India. Int J Res Med Sci. 2019 Nov 27;7(12):4433.	1.Google Scholar, 2.ISSN, 3.Index Copernicus	November 2019	4433
5	DR Manjunath I Nandennavar( first author)	Double malignancies: a clinicopathological and outcomes retrospective analysis from a tertiary cancer referral centre in South India.	International	Nandennavar MI, Angadi V, Karpurmath SV, Jacob R. Double malignancies: a clinicopathological and outcomes retrospective analysis from a tertiary cancer referral centre in South India. Int J Res Med Sci. 2019 Nov 27; 7(12):4449.	1.Google Scholar, 2.ISSN, 3.Index Copernicus	November 2019	4449

Number of Yearly research publications* by the teaching staff in 2020

S no	Author 1st, 2nd and corresponding author	Title of paper	National or International	Citation of the journal	Indexing details	Date of Publication	Page no. volume, ISSN no
01	Shashidhar V Karpurmath	Prognostic Significance of Molecular Profile in Non-metastatic Invasive Breast Cancer: A Multicentre Study from India	National	Rathnam, K., Niraimathi, K., Shewade, H.D. et al. Prognostic Significance of Molecular Profile in Non-metastatic Invasive Breast Cancer: A Multicentre Study from India. Indian J Gynecol Oncology 18, 36 (2020).	Scopus	Mar 2020	11
02	DR Shashidhar V Karpurmath ( Second Author)	Retrospective analysis of clinical manifestations and treatment outcomes of patients diagnosed with langerhans cell histiocytosis from a tertiary cancer hospital in South India.	International	Jacob RK, Karpurmath SV, Nandennavar M, Angadi V. Retrospective analysis of clinical manifestations and treatment outcomes of patients diagnosed with langerhans cell histiocytosis from a tertiary cancer hospital in South India. Int J Res Med Sci. 2020 May 26; 8(6):2128.	1.Google Scholar, 2.Issn, 3.Index Copernicus	May 2020	2128
03	Shashidhar V Karpurmath	Comparison of altered fractionation schedule with concurrent chemo-radiation for squmaous cell carcinoma of head and neck	International	K. MV, Narayanan GS, Vishwanathan B, Karpurmath SV, Narayanan S. Comparison of altered fractionation schedule with concurrent chemo-radiation for squamous cell carcinoma of head and neck. International Journal of Research in Medical Sciences. 2020 Jul 24;8(8):2834.	1.Google Scholar, 2.Issn, 3.Index Copernicus	Jul 2020	1-5
04	Dr. Shashidhar V Karpurmath ( First Author )	Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India.	International	Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, kumar S, Reddy N, et al. Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India. Clinical Lymphoma Myeloma and Leukemia. 2020 May; 20(5):e205-e211.	1.Pub-Med, 2.Indexmedicus/Medline, 3.Embase 4.Scopus 5.Science Citation Index Expanded	May 2020	e205-e211

Number of Yearly research publications* by the teaching staff in 2021

S no	Author 1st, 2nd and corresponding author	Title of paper	National or International	Citation of the journal	Indexing details	Date of Publication	Page no. volume, ISSN no
01	DR Manjunath I Nandennavar (First Author)	Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study	International	Nandennavar MI, Rathnam K, Murugesan J, Raman GS, Elangovan V, Chinnakali P, et al. Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study, South India. Int J Res Med Sci. 2021 Jan 29;9(2):423.	1.Google SCHOLAR, 2.ISSN, 3.INDEX COPERNICUS	January 2021	423
02.	DR Shashidhar v Karpurmath (Second author)	Role of Interim PET Scan after 2 Cycles of ABVD in Pediatric Hodgkin Lymphoma: Retrospective Multicenter Study from South India.	International	Karpurmath SV, Rathnam K, Seshachalam A, Srinivasan A, Scott J, G. RS, et al. Role of Interim PET Scan after 2 Cycles of ABVD in Pediatric Hodgkin Lymphoma: Retrospective Multicenter Study from South India. Indian J Med Paediatr Oncol. 2021 Oct;42(05):415-25.	1.INDMED 2.WEB Of SCIENCE 3. SCOPUS	October 2021	415-425

S no

Author 1st, 2nd and corresponding author

Title of paper

National or International

Citation of the journal

Indexing details

Date of Publication

Page no. volume, ISSN no

DR Manjunath I Nandennavar (First Author)

Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study

International

Nandennavar MI, Rathnam K, Murugesan J, Raman GS, Elangovan V, Chinnakali P, et al. Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study, South India. Int J Res Med Sci. 2021 Jan 29;9(2):423.

1.Google SCHOLAR,

2.ISSN,

3.INDEX COPERNICUS

January 2021

423

02.

DR Shashidhar v Karpurmath

(Second author)

Role of Interim PET Scan after 2 Cycles of ABVD in Pediatric Hodgkin Lymphoma: Retrospective Multicenter Study from South India.

International

Karpurmath SV, Rathnam K, Seshachalam A, Srinivasan A, Scott J, G. RS, et al. Role of Interim PET Scan after 2 Cycles of ABVD in Pediatric Hodgkin Lymphoma: Retrospective Multicenter Study from South India. Indian J Med Paediatr Oncol. 2021 Oct;42(05):415-25.

1.INDMED

2.WEB Of SCIENCE

3. SCOPUS

October 2021

415-425

Number of Yearly research publications* by the teaching staff in 2022

Sl. No	Author 1st, 2nd and corresponding author	Title of paper	National or International	Citation of the journal	Indexing details	Date of Publication	Page no.volume,ISSN no
01	Shashidhar V Karpurmath	An initial experience of computed tomography-guided trans superior vena caval biopsy: a novel approach for precarious mediastinal lesions	International	Rajasekaran M, Pandey S, Ashwathappa S, Mandakulutur GS, Karpurmath SV, Nandennavar MI. An initial experience of computed tomography-guided trans superior vena caval biopsy: a novel approach for precarious mediastinal lesions. Pol J Radiol. 2022 Apr 25;87:e233-e237.	Index Copurnicus Pubmed Central Scopus	Apr 2022	E233- E237
02	Veerendra Angadi (first author)	Clinicopathological features and prognostic factors in endometrial carcinoma: a retrospective analysis from a tertiary cancer centre	international	Angadi V, Praisy E, Tatineni T, Karpurmath SV, Nandennavar MI. Clinicopathological features and prognostic factors in endometrial carcinoma: a retrospective analysis from a tertiary cancer centre. International Journal of Research in Medical Sciences. 2022 Aug 29; 10(9):1925.	1.Google SCHOLAR, 2.ISSN, 3.INDEX COPERNICUS	Sep 2022	1925- 1929
03	Manjunath I Nandennavar (first author)	A Retrospective Study Of Diffuse Large B Cell Lymphoma (DLBCL) From A Tertiary Cancer Hospital In South India.	International	Nandennavar M, Nadella A, Priyanka Gv. A Retrospective Study Of Diffuse Large B Cell Lymphoma (Dlbcl) From A Tertiary Cancer Hospital In South India. International Journal Of Scientific Research. 2022 Sep 1; 73–4.	1. Google scholar 2. Pubmed central 3. Index Medicus	Sep 2022	73-74
04	Manjunath Nandennavar (first author)	An Experience Of Primary Amyloidosis From An Indian Tertiary Cancer Institute In South India.	International	Nandennavar M, Vishnu Priyanka G, Angadi V, V K S. An Experience Of Primary Amyloidosis From An Indian Tertiary Cancer Institute In South India. International Journal Of Scientific Research. 2022 Dec 1; 61–3.	1. Google scholar 2. Pubmed central 3. Index Medicus	Dec 2022	61-63

Number of Yearly research publications* by the teaching staff in 2023

Sl. No	Author 1st, 2nd and corresponding author	Title of paper	National or International	Citation of the journal	Indexing details	Date of Publication	Page no.volume, ISSN no
01	Shashidhar V Karpurmath (first author)	Tandem High dose chemotherapy with autologous bone marrow transplantation in germ cell tumour – Experience from a Tertiary care centre from South India	International	V. Karpurmath Shashidhar, Praisy E, I. Nandennavar Manjunath, Angadi V, Koshy Jacob R. Tandem High Dose Chemotherapy With Autologous Bone Marrow Transplantation In Germ Cell Tumor— Experience From A Tertiary Care Center From South India. International Journal Of Scientific Research. 2023 Jan 1; 81–3.	1. Google Scholar 2. Pubmed Central 3. Index Medicus	Jan 2023	81-83
02	Nitesh Anand, A Veerendra, Manjunath N, Shashidhar V K	A case series of hodgkins lymphoma with rare progression in the brain	International	Nitesh Anand, A Veerendra, Manjunath N, Shashidhar V K. A Case Series Of Hodgkin’s Lymphoma With Rare Progression In The Brain. International Journal Of Scientific Research	1. Indian Citation Index 2. NCBI 3. Pubmed Central 4. Open J Gate 5. DJOF 6. ICMJAE 7. DRJI 8. Index Medicus.	Sep 2023
03	A Veerendra, Nitesh Anand, Sachet Saxena, Manjunath N, Shashidhar V K	Clinical profiles and outcomes of young versus elderly patients with multiple myeloma : a retrospective observational study from a tertiary cancer center in south India	International	A Veerendra, Nitesh Anand, Sachet Saxena, Manjunath N, Shashidhar V K. Clinical profiles and outcomes of young versus elderly patients with multiple myeloma: a retrospective observational study from a tertiary cancer centre in south India Cancer Research, Statistics And Treatment.	1. DOAJ 2. SCIMAGO Journal Ranking 3. SCOPUS 4. EBSCO	25 Sep 2023
04	Dr A Praneeth Kumar, Dr Manjunath, Dr Vishnu Priyanka	Myeloproliferative hyper eosinophilic syndrome: chronic eosinophilic leukaemia	International	Praneeth Kumar (2023). Myeloproliferative Hypereosinophilic Syndrome – Chronic Eosinophilic Leukemia. MAR Oncology & Hematology (2023) 6:3.	1. Google Scholar 2. Pubmed Indexed ARTICLES 3. OPEN AIRE 4. PUBLONS 5. ICMJE	10/09/23
05	Dr Vishnu Vardhan Juture, Dr Gorla Vishnu Priyanka, Dr Sashidhar VK	A Rare presentation of Wilms Tumor in 2 Yr old child	International	DR VISHNU VARDHAN JUTURE, DR GORLA VISHNU PRIYANKA, DR SASHIDHAR VK. 2023. A Rare presentation of Wilms Tumor in 2 Yr old child. MAR Oncology & Haematology (2023)	1. GOOGLE SCHOLAR 2. Pubmed Indexed Articles 3. OPEN AIRE 4. PUBLONS 5. ICMJE	1/10/2023

Ongoing clinical trials

Phase-I studies- A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicentre, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies. Principal investigators-Dr.Shashidhar.V.K, Co-Investigators-Dr.Manjunath.N, Dr.Veerendra Angadi
Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas. Principal Investigator- Dr.Manjunath.I.N, CO-Investigators-Dr.Shashidhar.v.Karpurmath, Dr.Veerendra Angadi
NAGA trial: A phase III, multi centre RCT –Neoadjuvant vs adjuvant chemotherapy in gastric Adeno carcinoma. Principal investigators-Dr. Shashidhar. V.K, Co-Investigators-Dr. Manjunath. N, Dr. Veerendra Angadi

Completed clinical trials

Indication of trial	Phase of Trial	Role In Trial	Year
A phase IIb/III,Randomised, Double-blind, Placebo-Controlled, Multicentre, Study of CA-170 in combination with Chemotherapy in patients with Stage IV Non-Squamous Non-Small Cell lung Cancer.	Phase III	Principal Investigator	2023
An open label, Multi-Centre, Randomized, Two-Treatment, and Multi dose, parallel, Comparative Bioavailability Study of Bertezomib Injection 3.5mg/0.2ml and VECADE 3.5mg powder for solution for injection at a dose of .3mg/m2 in Multiple Myeloma Patients.	Phase-III	Co- Investigator	2021
A multi-centre, Double-Blind, randomized parallel Group, Active controlled, Two Part, Phase-III, Global Study to Evaluate the Pharmacokinetics, Effiacy,and Safety of BP 02 (Trastuzumab) in Comparison with Herceptin- EU in patients with Her2-positive Early Breast Cancer and Metastatic Breast Cancer.	Phase-III	Co- Investigator	2019-2022
Prospective , multi-center, randomized,double-blind,two-arm,parallel group, active control, comparative clinical study to evaluate efficacy and safety of R-TPR_045/Xgeva for prevention of skeletal related events in patients with bone metastases from solid tumours.	Phase-III	Co- Investigator	2018-2019
Metastatic Breast Cancer	Phase-III	Principal Investigator	2017-2018
A prospective , Multicenter, randomize, double blind, phase III study to compare the efficacy and safety of Biosimilar Bevacizumab of Enzene Biosciences LTD versus Innovator Bevacizumab both in combination with CAPEOX in Patients with Metastatic Colorectal Cancer	Phase-III	Principal Investigator	2016-2017
A randomized open label single dose two treatment three sequence partial replicate cross over multicenter bioequivalence study of Capecitabine 500 mg tablets with Xeloda in adult cancer patients under fed conditions- Completed US FDA inspection for the same.	Phase-III	Principal Investigator	2018-2019

ICMR Project study

To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients.
Research proposal accepted by ICMR under STS (Short term Studentship) for the year 2020.

Shashidhar V Karpurmath , Professor & HOD

Awards and Laurels

Shashidhar V Karpurmath won the 1st prize ORAL PRESENTATION in the HAEMATO-ONCOLOGY section in REAL WORLD EVIDENCE NATIONAL CONFERENCE 2019.
Cleared ESMO certification exam in 2019.
Awarded as the BEST PHYSICIAN of 2019 in RESEARCH CATEGORY at Vydehi.
Is currently, the ORGANISING SECRETARY of COLLABORATIVE MEDICAL ONCOLOGY GROUP (CMOG).
Got approval for conducting ICMR project as guide to MBBS student in the year 2020 titled “To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients”.

International Conferences

ESMO update for practicing oncologists 2018, Lugano, Switzerland.
Attended the per mentorship programme in Frankfurt Germany at UKGM (GIESSEN university) in SEPTEMBER 2016.

National Conferences

Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.
Attended and completed ‘STRUCTURED OPERATIONAL RESEARCH TRAINING INITIATIVE’ course conducted by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO.
Was invited as a speaker at APEX PROFESSIONAL UNIVERSITY on the occasion of WORLD CANCER DAY 2021- delivered a talk titled ‘IS DIAGNOSIS OF CANCER ALWAYS A DEATH SENTENCE’.
Was appointed as subject expert as part of Local Inspection Committee from RGUHS regarding inspections in KIDWAI Memorial Institute Of Oncology, March 2021.
Was appointed as subject expert as part of Expert Committee regarding promotion of the faculty in medical Oncology at KIDWAI 2019, M.S.Ramiah 2019, Manipal Academy of Higher Education 2019.

Presentations in the last 5 years

Invited as a guest speaker in ‘SPOTLIGHT ON PRECISION ONCOLOGY CONFERENCE ‘held at Chennai on 25^thmay 2024.
Attended module 3 of SORT IT (Structured operational research training initiative) held at Cachar cancer centre, Silchar Assam in May 7-12, 2024 an initiative of ICMR –NIE.
Invited as a speaker in the 2^ndInternational global cancer consortium conference held at KMC Manipal on Jan 7^th
Attended as an invited faculty for the 8^thedition of year in review breast cancer conference at Mumbai 22^nd Jan 2023.
Attended the CMOG ( Collaborative Medical oncology Group ) meeting at Bengaluru on 13/03/2022
Invited as Guest Speaker in the CME conducted by G V N Cancer Centre and IMA Trichy at Trichy on 05/06/2022 and delivered his lecture on the topic – Oncology-Physician Rapport in Shared care Model
Invited as faculty and participated as a panelist in the “Cancer Pain Management “CME held on 15/10/2022 at Vydehi Institute of Medical Sciences and Research Centre.
Invited as faculty and participated as guest speaker and gave a talk in a national webinar on “Recent advances in Lung Cancer Management “ in the CME – Recent Advances in Pulmonology on 06/12/2022, conducted by the Department of Pulmonology, Vydehi Institute Of Medical Sciences and Research Centre .
Halving time of BCR-Abl1 levels –Is it a better Bet than day 90 Bcr-Abl1 in chronic phase Chronic Myeloid leukemia patients .Presented in Real world Evidence – National conference conducted at Chennai in august 2019.
Presented the Data on GIST in conference conducted by collaborative Medical Oncology Group at Vijayawada in 2018.
Presented –Should different types of Breast Cancer be staged differently in National conference Breast con 2018, held at Kasturba Medical College Manipal.
Presented the Hospital data at NCDIR meeting held at Bengaluru and also took part in the meeting for consensus on POCSS form for Hematological malignancies for Hospital Based cancer Registries in 2018
Presented in Indian Cancer Congress 2017 held in Bengaluru in a Genitor-Urinary session.
Presented in Molecular Tumor Board of CML – International Conference held in Chennai in 2016.
Presented a poster in ISMPO-ISO conference held in Mumbai in 2015.
Attended the CMOG (Collaborative Medical oncology Group) meeting at Bengaluru on 13/03/2022
Attended the “Cancer Pain Management “CME held on 15/10/2022 at Vydehi Institute of Medical Sciences and Research Centre.
Attended the national webinar on “Recent advances in Lung Cancer Management “ in the CME – Recent Advances in Pulmonology on 06/12/2022,conducted by the Department of Pulmonology, Vydehi Institute Of Medical Sciences and Research Centre
Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.

Recognized by University for additional roles & responsibilities

Appointed as External Member of Board of Studies for Medical Oncology at Kasturba Medical College, Manipal Academy of Higher Education (MAHE) from 2020 to 2024
Appointed as part of Local inspection committee as subject expert for Inspection at Kidwai cancer centre as per the appointment order RGU/AC2/AFF/MED/LIC/2020-21 dated 26/02/2021
Appointed to monitor the research activities pertaining to 2 Medical Oncology Research projects for the year 2018-19 as per the appointment order RGU/ADV-RES/BR/001/2018-19 dated 15/09/2020
Appointed as External examiner for the DM Medical Oncology practical exams at Amrita Vishwa Vidyapeetha, Kochi; Sri Aurobindo Institute of Medical College, Indore; Madras Medical College, Chennai; Madurai Medical College, Madurai; Kasturba Medical College, Manipal from 2017 to 2024
Appointed as Internal examiner for the DM Medical Oncology practical exams at Kidwai memorial Institute of Oncology in the year 2017 and 2018
Appointed as Internal examiner for the DM Medical oncology practical Examinations at Vydehi Institute of medical Sciences and Research Centre in the years 2016, 2017, 2019, 2021 and 2023
Has been appointed as part of Committee as Subject expert in Medical Oncology for the selection / promotion for the faculty of Medical Oncology at Kidwai memorial Institute of oncology, Kasturba Medical College and at MS Ramaiah Medical College from 2019 to 2024

Projects undertaken in the last 5 years

To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients
As a guide to MBBS student ,Ongoing project , research proposal accepted by ICMR under STS (Short term Studentship) for the year 2020
Multi-Centre study was undertaken and completed as part of SORT IT (Structured Operational Research Training Initiative) by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO in 2018-19 – Halving Time of Bcr-Abl1 compared to conventional Day 90 Bcr-Abl1 in chronic myeloid leukemia patients in chronic phase.
Worked as Co-investigator for Neo-adjuvant chemo-radiation therapy in T4 resectable oral cavity cancer project undertaken in the Department of oncology at Vydehi Institute of Medical Sciences and Research Centre 2017-2019
As a guide to DM Medical oncology Post graduate for the project -Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population in 2017-2018
As a coinvestigator to the project -Novel single day premedication regimen for prevention of paclitaxel induced hypersensitivity reaction 2017
Ongoing project as PI – One of the participating centres for the phase III, multi centre RCT –NAGA (Neoadjuvant vs adjuvant chemotherapy in gastric adeno ca).
Manjunath Nandennavar , Professor

International Conferences

Attended ICC conference in Delhi, 2013 and Bangalore, 2019 as a delegate.

Invited as faculty / speaker – National conferences

Attended the CMOG ( Collaborative Medical oncology Group ) meeting at Bengaluru on 13/03/2022
Attended the “Cancer Pain Management “CME held on 15/10/2022 at Vydehi Institute of Medical Sciences and Research Centre.
Attended the national webinar on “Recent advances in Lung Cancer Management “in the CME – Recent Advances in Pulmonology on 06/12/2022, conducted by the Department of Pulmonology, Vydehi Institute of Medical Sciences and Research Centre.
Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.
.Presented ‘Comparison of outcomes of 5FU vs. Taxane based chemotherapy regimens in metastatic stomach cancer: results from a tertiary cancer center in south India’ in Real world Evidence – National conference conducted at Chennai in august 2019.

Projects undertaken in the last 5 years

As a guide to MBBS student, Ongoing project, research proposal accepted by ICMR under STS (Short term Studentship) for the year 2023.
Multi-center study was undertaken and completed as part of SORT IT (Structured Operational Research Training Initiative) by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO in 2018-19 –Comparison of outcomes of 5FU vs. Taxane based chemotherapy regimens in metastatic stomach cancer: results from a tertiary cancer center in south India.
As a PI in Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas.
As a CO PI in Phase-I studies- A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicenter, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies
As a CO PI in NAGA trial: A phase III, multi centre RCT –Neoadjuvant vs adjuvant chemotherapy in gastric Adeno carcinoma. Principal investigators

Recognized by University for additional roles & responsibilities

Appointed as external examiner for the DNB Medical Oncology practical exams at Madurai Meenakshi mission institute in February 2024.
Appointed as Internal examiner for the DM Medical oncology practical Examinations at Vydehi Institute of medical Sciences and Research Centre in the years 2019,2020,2021,2022 and 2023.
Has been appointed as part of Committee as Subject expert in Medical Oncology for the selection / promotion for the faculty of Medical Oncology at MS Ramaiah medical college in 2024.
Veerendra Angadi , Assistant Professor

National Conferences

Attended ISMPO ISO conference in Nov 2015. Presented POSTER presentation on Progressive Multifocal Leukoencephalopathy-Rare demyelinating disorder in a patient with SLL.
VICON 2014, Vydehi Institute of Medical sciences and Research centre, Bangalore.
Pediatric oncology CME programme at Shankara cancer Hospital, Bangalore.
CME on Gastric and OG Junction cancers: Update.

Clinical Research Experience

A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicentre, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies. Co-Investigator.
A phase IIb/III, Randomized, Double-blind, Placebo-Controlled, Multicenter, Study of CA-170 in combination with Chemotherapy in patients with Stage IV Non-Squamous Non-Small Cell lung Cancer. Co-Investigator.
A Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas. Co-Investigator.
An open label, Multi-Centre, Randomised, Two-Treatment, Multi dose, parallel, Comparative Bioavailability Study of Bertezomib Injection 3.5mg/0.2ml and VECADE 3.5mg powder for solution for injection at a dose of .3mg/m2 in Multiple Myeloma Patients. Co-Investigator.
A multi-centre, Double-Blind, randomized parallel Group, Active controlled, Two Part, Phase-III, Global Study to Evaluate the Pharmacokinetics, Effiacy,and Safety of BP 02(Trastuzumab) in Comparison with Herceptin- EU in patients with Her2-positive Early Breast Cancer and Metastatic Breast Cancer. Co-Investigator.
Prospective , multi-centre, randomized, double-blind, two-arm, parallel group, active control, comparative clinical study to evaluate efficacy and safety of R-TPR_045/Xgeva for prevention of skeletal related events in patients with bone metastases from solid tumors. Co-Investigator.

RGUHS UNIVERSITY RANK HOLDERS IN DM MEDICAL ONCOLOGY

Dr. Vishnu Priyanka J- 5^th Rank in 2023
Dr. Swaroopa Chundru- 3^rd Rank in 2021
Dr. Mehlam Kausar- 4^th Rank in 2020
Dr. Sai Vivek V- 2^nd Rank in 2019

Academic laurels and Achievements of DM Medical Oncology Residents

Sl. No	SS PG Name	Event /Conference	Prize /Presentation	Topic	Date / Month &Year
I	Dr. Subha Supriya
	1	ISMPO / ISOCON 2022	Oral presentation	Rare case report on Synovial Sarcoma in Infancy.	October 2022
	2	GI CON	Oral presentation	MANEC	May 2023,
	3	Nuclear Medicine Updates	CME	Nuclear Medicine Updates	DEC 23
	4	Best of ASCO	Oral presentation		MARCH 2024
	5	AMOI	2^ND PRIZE	AMOI Crossword	MARCH 2024
II	Dr. Shruthi Swamy
	1	AMOI	1^ST PRIZE	Oncology Premier League Quiz	June 2022
	2	AMOI	1^ST PRIZE	Debate on Can Triple therapy be made SOC in MCSPC	September 2022
	3	ISMPO / ISOCON 2022	Oral presentation	Institutional experience of PCNSL at a tertiary care centre	October 2022
	4	ISMPO / ISOCON 2022	Oral presentation	Thiotepa based auto MT in PCNSL	October 2022
	5	ISMPO / ISOCON 2022	Oral presentation	Review article on Triplet Therapy in MCSPC	October 2022
	6	AMOI	1^ST PRIZE	Grand Quiz(Oncology Premier League Finals)	November 2022
	7	AMOI	3^rd prize	Oncology Premier League Quiz	August 2023
	8	Best of ASCO	Oral presentation	CONTACT study phase III trial- Atezolizumab+ Cabozantinib in MRCC	MARCH 2024

III	Dr. Praneetha
	1	AMOI	1^ST PRIZE	AMOI Quiz	AUG 2023
	2	AMOI	2^ND PRIZE	AMOI Crossword	MARCH 2024
	3	RWE	Oral Presentation	Is FLOT really superior?? A Real world experience from a tertiary cancer centre in India in locally advanced gastric cancer	April,2023
	4	ISMPO- ISOCON	Oral Presentation	Chronic Myeloid Leukemia in a 3year old child- a rare case report	Oct,2022
IV	Dr. Nitesh Anand
	1	AMOI	1^ST PRIZE	Debate on Can Triple therapy be made SOC in mCSPC	September 2022
	2	AMOI	3^RD PRIZE	AMOI Quiz	JAN 2024
	3	AMOI	3^RD PRIZE	AMOI Quiz	MARCH 2024
	4	RWE	POSTER PRESENTATION	MULTIPLE MYELOMA IN YOUNG , INSTITUTIONAL EXPERIENCE	April,2023
	5	Best of ASCO	Oral presentation	ADJUVANT OSIMERTINIB IN ADENO CA LUNG	MARCH 2024

V	Dr. Sachet Saxena
	1	RWE	ORAL PRESENTATION	BMT INSTITUTIONAL EXPERIENCE	April,2023
	2	Best of ASCO	Oral presentation	PEMBROLIZUMAB IN TKI RESISTANT ADENO CA LUNG	MARCH 2024

Dr.Shashidhar V Karpurmath

Dr.Manjunath Nandennavar

Dr.Veerendra Angadi

Dr.Santoshkumar S Asangi

Dr.Chevireddy Praneetha

Dr A Praneeth Kumar

Dr.Geetika Dandamudi

Dr.Mohammed Hafeez

Dr.Nitesh Anand

Dr.Pooja D

Dr.Prakash Shashikant Mishra

Dr.Ranjitha Raj

Dr.Sachet Saxena

Dr.Shruthi Swamy

Dr.Shubha Supriya A

Dr.Vishnu Vardhan Juture

Dr.Yedla Srinivasa Vishnuvardhan

Dr.Yogitha C

Supportive services

Specialty Clinics

Outpatient Facilities

Inpatient Facilities

Publications from the department during the past 05 years: Number of Yearly research publications* by the teaching staff in 2018

Number of Yearly research publications* by the teaching staff in 2019

Number of Yearly research publications* by the teaching staff in 2020

Number of Yearly research publications* by the teaching staff in 2021

Number of Yearly research publications* by the teaching staff in 2022

Number of Yearly research publications* by the teaching staff in 2023

Ongoing clinical trials

Completed clinical trials

ICMR Project study

Shashidhar V Karpurmath , Professor & HOD

Awards and Laurels

International Conferences

National Conferences

Presentations in the last 5 years

Recognized by University for additional roles & responsibilities

Projects undertaken in the last 5 years

International Conferences

Invited as faculty / speaker – National conferences

Projects undertaken in the last 5 years

Recognized by University for additional roles & responsibilities

National Conferences

Clinical Research Experience

RGUHS UNIVERSITY RANK HOLDERS IN DM MEDICAL ONCOLOGY